ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
FDA Approves Twyneo (tretinoin and benzoyl peroxide) for the Treatment of Acne Vulgaris
July 28, 2021Sol-Gel Technologies, Ltd. today announced that FDA has approved its first proprietary drug product, Twyneo cream, 0.1%/3%, indicated for the treatment of acne vulgaris in adults and pediatric patients nine years of age and older. -
Kintor Pharmaceuticals Announced Successful Dosing of the First Batch of Patients for Acne Vulgaris Phase I/II Clinical Trial of Pyrilutamide
April 19, 2021Kintor Pharmaceutical Limited, a clinical-stage biotechnology company developing small molecule and biological therapeutics, announced the clinical trial of Pyrilutamide as a treatment for the acne vulgaris has completed the first batch of patients ... -
Aleor Dermaceuticals gets US FDA nod for Adapalene Gel USP
June 22, 2020It is indicated for the topical treatment of acne vulgaris in patients 12 years of age and older.
Pharma Sources Insight January 2025
